HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors of functional improvement in the short term after MitraClip implantation in patients with secondary mitral regurgitation.

AbstractBACKGROUND AND OBJECTIVES:
MitraClip implantation is an established therapy for secondary mitral regurgitation (MR) in high-risk patients and has shown to improve several important outcome parameters such as functional capacity. Patient selection is both challenging and crucial for achieving therapeutic success. This study investigated baseline predictors of functional improvement as it was quantified by the six-minute walk distance (6MWD) after transcatheter mitral valve repair.
METHODS AND RESULTS:
We retrospectively analyzed 79 patients with secondary MR treated with MitraClip implantation at an academic tertiary care center. Before and four weeks after the procedure, all patients underwent comprehensive clinical assessment, six-minute walk tests and echocardiography. 6MWD significantly improved after MitraClip therapy (295 m vs. 265 m, p < 0.001). A linear regression model including seven clinical baseline variables significantly predicted the change in 6MWD (p = 0.002, R2 = 0.387). Female gender, diabetes mellitus and arterial hypertension were found to be significant negative predictors of 6MWD improvement. At baseline, female patients had significant higher left ventricular ejection fraction (49% vs. 42%, p = 0.019) and lower 6MWD (240 m vs. 288 m, p = 0.034) than male patients.
CONCLUSION:
MitraClip implantation in secondary MR significantly improves functional capacity in high-risk patients even in the short term of four weeks after the procedure. Female gender, diabetes mellitus and arterial hypertension are baseline predictors of a less favourable functional outcome. While further validation in a larger cohort is recommended, these parameters may improve patient selection for MitraClip therapy.
AuthorsMichael G Paulus, Christine Meindl, Lukas Böhm, Magdalena Holzapfel, Michael Hamerle, Christian Schach, Lars S Maier, Kurt Debl, Bernhard Unsöld, Christoph Birner
JournalPloS one (PLoS One) Vol. 15 Issue 5 Pg. e0232817 ( 2020) ISSN: 1932-6203 [Electronic] United States
PMID32463820 (Publication Type: Journal Article)
Topics
  • Aged
  • Cardiac Surgical Procedures (methods)
  • Coronary Disease (physiopathology, therapy)
  • Echocardiography
  • Female
  • Heart (physiopathology)
  • Heart Failure (physiopathology, therapy)
  • Heart Valve Prosthesis Implantation
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve (physiopathology)
  • Mitral Valve Insufficiency (physiopathology, therapy)
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: